Physician profile
Dennis Guest
NPI 1750801304
$641.08
in general payments reported to CMS, 2019-2025
12 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.01 · 2022: $140 · 2023: $96.49 · 2024: $208 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $139.31 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $112.73 | 2022-2025 | |
| Lilly USA, LLC | $109.73 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Exact Sciences Corporation | $65.20 | 2024-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $51.95 | 2024-2025 | Lagevrio, Dificid, M-M-R II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.21 | 2023-2024 | Jardiance, Synjardy |
| Astrazeneca Pharmaceuticals Lp | $27.32 | 2022-2024 | Airsupra |
| Philips North America LLC | $26.70 | 2022 | |
| Glaxosmithkline, LLC. | $15.78 | 2024 | Shingrix |
| Idorsia Pharmaceuticals US INC | $15.33 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.18 | 2024 | |
| Sanofi Pasteur INC. | $13.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Guest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.